+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 14Years +
All Genders
ID07548177

Phase II Study of Benmelstobart Injection Combined With Anlotinib Capsules for Treating Advanced or Unresectable Alveolar Soft Part Sarcoma in Patients 14 Years and Older

Led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Updated on 2026-04-23

33

Participants Needed

15

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of benmelstobart injection and anlotinib hydrochloride capsules in patients aged 14 years or older with advanced or unresectable alveolar soft part sarcoma. This Phase II, single-arm, multicenter clinical study aims to assess the objective response rate based on independent review committee IRC assessment. The study is sponsored by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and is designed to explore treatment options for this rare type of cancer without previous systemic therapy. Participants will receive benmelstobart injection combined with anlotinib hydrochloride capsules in 21-day treatment cycles. Benmelstobart acts as a PD-L1 immunosuppressant, while anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor. The study does not include a comparison group and follows a single-arm design, focusing on evaluating the treatment effect over time. Throughout the expected 32-month trial period, participants will undergo regular evaluations to measure outcomes such as objective response rate, disease control rate, duration of remission, and progression-free survival, assessed both by IRC and researchers. Follow-up includes survival monitoring up to an estimated 48 months from baseline. Safety is monitored by recording adverse events and laboratory tests. Participants will be closely observed for treatment effects and side effects during and after treatment.

CONDITIONS

Brief Title

Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma

Research Team

J

Jiayong Liu, Doctor

J

Jing Chen, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here